CCRM
Vismay Patel is an experienced biotechnology professional with a strong background in operations and manufacturing within the biopharmaceutical industry. Currently serving as an Operations Associate II at CCRM since June 2021, Vismay specializes in documenting change control processes and performing environmental monitoring for cleanroom environments. Prior experience includes roles as a Manufacturing Technician at Therapure Biopharma Inc./Resilience Biotechnology Inc., where Vismay operated key bioprocessing equipment and supported upstream and downstream manufacturing operations, and as a Process Operator at Teva Pharmaceuticals, ensuring compliance with standard operating procedures and good manufacturing practices. Vismay's educational background includes a Biotechnology degree from Centennial College and a Bachelor of Biotechnology from Government Science College.
CCRM
1 followers
Regenerative Medicine (RM), which aims to harness the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs, has the promise to treat, manage and perhaps cure some of the most devastating and costly diseases in the world today. Many new and potentially life-changing RM-based treatments never reach patients because they are not successfully moved from the laboratory to a stage where they can be used in medicine. In order to fulfill RM’s promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and engineers have come together to form CCRM, a leader in developing and commercializing regenerative medicine and cell therapy technologies. CCRM formally launched on June 14, 2011. CCRM supports the development and commercialization of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy.